Literature DB >> 28899760

Chronic atypical antipsychotics, but not haloperidol, increase neurogenesis in the hippocampus of adult mouse.

Koji Chikama1, Hidetaka Yamada2, Tatsuo Tsukamoto1, Kosuke Kajitani3, Yusaku Nakabeppu4, Naohisa Uchimura1.   

Abstract

It is suggested that altered neuroplasticity contributes to the pathophysiology of schizophrenia and antipsychotics may exhibit some of their therapeutic efficacies by improving neurogenesis and/or proliferation of neural progenitors. The aim of this study is to investigate whether chronic antipsychotics treatment affect neurogenesis in adult mouse hippocampus. Animals were administered olanzapine, quetiapine, clozapine, risperidone, aripiprazole, or haloperidol via the osmotic minipump for 21days and then injected with 5-bromo-2'-deoxyuridine (BrdU) to label mitotic cells. BrdU-positive cells in the hippocampus were quantified by stereology. Aripiprazole, quetiapine, clozapine, and olanzapine significantly increased density of BrdU-positive cells in the hippocampus. Interestingly, other antipsychotic drugs had tendency to increasing BrdU-positive cells, whereas haloperidol had propensity to decrease with a marginal significance. These results suggest that differences of neurogenesis among these drugs may, at least in part, account for their pharmacological profiles.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-bromo-2′-deoxyuridine (BrdU); Antipsychotics; Hippocampus; Mouse; Neurogenesis; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28899760     DOI: 10.1016/j.brainres.2017.09.006

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  ADULT NEUROGENESIS IN HUMANS: A Review of Basic Concepts, History, Current Research, and Clinical Implications.

Authors:  Ashutosh Kumar; Vikas Pareek; Muneeb A Faiq; Sanjib K Ghosh; Chiman Kumari
Journal:  Innov Clin Neurosci       Date:  2019-05-01

2.  Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia.

Authors:  Daniel R Garton; Ana R Montaño-Rodríguez; Soophie Olfat; Kärt Mätlik; Feride Eren; Laoise Casserly; Anastasios Damdimopoulos; Anne Panhelainen; L Lauriina Porokuokka; Jaakko J Kopra; Giorgio Turconi; Nadine Schweizer; Erika Bereczki; Fredrik Piehl; Göran Engberg; Simon Cervenka; T Petteri Piepponen; Fu-Ping Zhang; Petra Sipilä; Johan Jakobsson; Carl M Sellgren; Sophie Erhardt; Jaan-Olle Andressoo
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 15.992

3.  Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients.

Authors:  Katarzyna Waszczuk; Jolanta Kucharska-Mazur; Ernest Tyburski; Katarzyna Rek-Owodziń; Piotr Plichta; Krzysztof Rudkowski; Piotr Podwalski; Tomasz Grąźlewski; Monika Mak; Błażej Misiak; Anna Michalczyk; Maciej Tarnowski; Katarzyna Sielatycka; Angelika Szczęśniak; Karolina Łuczkowska; Barbara Dołęgowska; Marta Budkowska; Mariusz Z Ratajczak; Jerzy Samochowiec
Journal:  Int J Environ Res Public Health       Date:  2022-05-15       Impact factor: 4.614

4.  Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: A comparison with matched treatment-responsive patients and healthy controls✰,✰✰,★,★★.

Authors:  Junchao Huang; Yu Zhu; Fengmei Fan; Song Chen; Yuan Hong; Yimin Cui; Xingguang Luo; Shuping Tan; Zhiren Wang; Lan Shang; Ying Yuan; Jianxin Zhang; Fude Yang; Chiang-Shan R Li; Laura M Rowland; Peter Kochunov; Fengyu Zhang; L Elliot Hong; Yunlong Tan
Journal:  Psychiatry Res Neuroimaging       Date:  2020-02-04       Impact factor: 2.376

5.  Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostanaLinn. (Mangosteen) Pericarp for Schizophrenia.

Authors:  Alyna Turner; John J McGrath; Olivia M Dean; Seetal Dodd; Andrea Baker; Susan M Cotton; James G Scott; Bianca E Kavanagh; Melanie M Ashton; Adam J Walker; Ellie Brown; Michael Berk
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

Review 6.  Wnt/β-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind.

Authors:  Joanna Bem; Nikola Brożko; Chaitali Chakraborty; Marcin A Lipiec; Kamil Koziński; Andrzej Nagalski; Łukasz M Szewczyk; Marta B Wiśniewska
Journal:  FEBS Lett       Date:  2019-06-30       Impact factor: 4.124

7.  Clozapine protects adult neural stem cells from ketamine-induced cell death in correlation with decreased apoptosis and autophagy.

Authors:  Mathias Lundberg; Sophie Curbo; Hannes Bohman; Ingrid Agartz; Sven-Ove Ögren; Cesare Patrone; Shiva Mansouri
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 8.  Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Biomedicines       Date:  2021-04-26

9.  Transcriptional Effects of Psychoactive Drugs on Genes Involved in Neurogenesis.

Authors:  Chiara C Bortolasci; Briana Spolding; Srisaiyini Kidnapillai; Timothy Connor; Trang T T Truong; Zoe S J Liu; Bruna Panizzutti; Mark F Richardson; Laura Gray; Michael Berk; Olivia M Dean; Ken Walder
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

10.  Chlorpromazine affects the numbers of Sox-2, Musashi1 and DCX-expressing cells in the rat brain subventricular zone.

Authors:  Jakub Skałbania; Artur Pałasz; Iwona Błaszczyk; Aleksandra Suszka-Świtek; Marek Krzystanek; Karina Paola Tulcanaz; John J Worthington; Kinga Mordecka-Chamera
Journal:  Pharmacol Rep       Date:  2021-04-12       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.